Molecular prognostic factors in small-intestinal neuroendocrine tumours

Autor: K G Samsom, L M van Veenendaal, G D Valk, M R Vriens, M E T Tesselaar, J G van den Berg

Publikováno v: Endocrine Connections, Vol 8, Iss 7, Pp 906-922 (2019)

Background: Small-intestinal neuroendocrine tumours (SI-NETs) represent a heterogeneous group of rare tumours. In recent years, basic research in SI-NETs has attempted to unravel the molecular events underlying SI-NET tumorigenesis. Aim: We aim to pr

Externí odkaz: https://doaj.org/article/7893382d45614600986217034b9df75d

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

Autor: W. W. de Herder, L. D. de Hosson, Y. Schuller, Annemiek M E Walenkamp, Heinz-Josef Klümpen, Wouter T Zandee, Margot E T Tesselaar, L. M. van Veenendaal

Publikováno v: Annals of Oncology, 28(12), 3022-3027. Oxford University Press
Annals of oncology, 28(12), 3022-3027. Oxford University Press
Annals of Oncology, 28(12), 3022-3027. Elsevier Ltd.

Background: Assessment of clinical benefit of systemic treatments of rare diseases including gastroenteropancreatic neuroendocrine tumours (GEP-NET) is challenging. Recently several tools have been developed to grade the clinical benefit of cancer dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddee44cc96057b94f9d456928fe843a4
https://doi.org/10.1093/annonc/mdx547